½ÃÀ庸°í¼­
»óǰÄÚµå
1314947

¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : ÇÁ·Î¼¼½ºº°, ÀÚµ¿È­ À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Lab Automation Market Size study & Forecast, by Process, By Automation Type, By End-use and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀº 2022³â ¾à 56¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2023³âºÎÅÍ 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È 8.1% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀº »ùÇà Á¶Á¦, µ¥ÀÌÅÍ ºÐ¼®, Å×½ºÆ®¿Í °°Àº ½ÇÇè½Ç Ȱµ¿À» ÀÚµ¿È­Çϱâ À§ÇÑ ±â¼ú ¹× ÀåºñÀÇ Àû¿ë°ú °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ½ÇÇè½Ç ÀÚµ¿È­´Â Á¦¾à, »ý¸í°øÇÐ, ÀÓ»ó Áø´Ü, Çмú ¿¬±¸ µî ´Ù¾çÇÑ ºñÁö´Ï½º¿¡¼­ º¸ÆíÈ­µÇ°í ÀÖ½À´Ï´Ù. ÀÚµ¿È­´Â 󸮷®À» ³ôÀ̰í, ½ÇÇèÀÇ Á¤È®¼º°ú ÀçÇö¼ºÀ» Çâ»ó½Ã۸ç, Àΰ£¿¡ ÀÇÇÑ º¯µ¿¼º°ú ¿À·ù¸¦ Á¦°ÅÇÏ¿© ½ÇÇèÀÇ Á¤È®¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ÀÌ ¸ðµç °ÍÀÌ º¸´Ù ½Å¼ÓÇϰí È¿°úÀûÀÎ ¿¬±¸°³¹ß·Î À̾îÁý´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Á¦¾à »ê¾÷¿¡¼­ ´õ ºü¸¥ ¿¬±¸ °³¹ßÀÇ Çʿ伺, ½ÇÇè½ÇÀÇ µðÁöÅÐÈ­ ¹× ÀÚµ¿È­¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ Ãß¼¼·Î ÀÎÇØ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀº ÇâÈÄ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ½ÅÈï±¹ Àüü¿¡¼­ ´õ ºü¸¥ ¿¬±¸ °³¹ß ¹× ÀÇ·á ÁïÈïÈ­¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϸ鼭 ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. Invest India¿¡ µû¸£¸é ÀεµÀÇ ÀÇ·á ±â¼ú ºÎ¹®Àº 2030³â±îÁö 110¾ï ´Þ·¯ÀÇ °¡Ä¡°¡ ÀÖÀ¸¸ç Áö³­ 3³â°£ 15%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±¹Á¦¹«¿ª±¹¿¡ µû¸£¸é 2023³â Áß±¹ ÀÇ·á±â±â ºÎ¹®Àº 2021³âºÎÅÍ 2026³â±îÁö 8.3%ÀÇ CAGR·Î ¼ºÀåÇØ 488¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áß±¹ ÀÇ·á±â±â ¼öÀÔ ºÎ¹®ÀÇ 4ºÐÀÇ 3Àº ¹Ì±¹ °ø±Þ¾÷ü·Î ±¸¼ºµÇ¾î ÀÖÀ¸¸ç, 2021³â Áß±¹ ÀÇ·á±â±â ¼öÀÔ¾× 56¾ï 2,000¸¸ ´Þ·¯ÀÇ 27.2%¸¦ Â÷ÁöÇß½À´Ï´Ù. ¿µ»óÁø´Ü ¹× ¼Ò¸ðǰÀÌ ÀÇ·á±â±â ½ÃÀå °¡Ä¡ÀÇ 50% ÀÌ»óÀ» Â÷ÁöÇß½À´Ï´Ù. ¶ÇÇÑ ½ÇÇè½Ç ÀÚµ¿È­ ¾ÖÇø®ÄÉÀ̼ÇÀÇ Áõ°¡·Î ÀÎÇØ °¡±î¿î Àå·¡¿¡ ½ÃÀå ¼ºÀåÀÌ °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿©±â¿¡´Â ¼¼Æ÷ÁÖ »ý¼º, ÇÕ¼º»ý¹°ÇÐ, À¯ÀüüÇÐ, ¼¼Æ÷ °Ë»ç, ½Å¾à °³¹ß µîÀÌ Æ÷ÇԵ˴ϴÙ. °¡±î¿î Àå·¡¿¡ ½ÃÀå ¼ºÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµÇ´Â ¶Ç ´Ù¸¥ ¿äÀÎÀº ¼ÒÇüÈ­¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. ±×·¯³ª Áß¼Ò ±Ô¸ðÀÇ »ê¾÷¿¡¼­ ½ÇÇè½Ç ÀÚµ¿È­¸¦ µµÀÔÇÏ±â ¾î·Æ´Ù´Â Á¡ÀÌ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå ¼ºÀåÀÇ Á¦¾à ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

¼¼°è ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå Á¶»ç¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áö¿ªÀ¸·Î´Â ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«°¡ ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â 2022³â ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È ÀÌ ÁöÀ§¸¦ À¯ÁöÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. Àß ±¸ÃàµÈ ÀÇ·á ÀÎÇÁ¶óÀÇ Á¸Àç´Â ÀÌ Áö¿ªÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ±â¼ú µµÀÔ Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ ÁÖ¿ä ±â¾÷ÀÇ ÇöÁö Á¸Àç¿Í Áö¿øÀûÀÎ »óȯ ½Ã½ºÅÛÀº Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀÇ ½ÃÀå ħÅõ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ½ÃÀå¿¡¼­ »õ·Î¿î ½ÇÇè½Ç ÀÚµ¿È­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¾×¼¼½º¸¦ Á¦°øÇϱâ À§ÇÑ Áö¿ª ¹× ±¹Á¦ ±â¾÷ÀÇ ³ë·Â Áõ°¡¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â µ¿¾È ´Ù¾çÇÑ ºÎ¹® ¹× ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ Á¤ÀÇÇϰí ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â ¿¬±¸¿¡ Âü¿©ÇÑ ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» Á¤ÀÇÇÏ´Â ÃËÁø¿äÀÎ ¹× °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, °æÀï ȯ°æ°ú ÁÖ¿ä ±â¾÷ÀÇ Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀåÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇԵŠÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇöȲ
  • ¼¼°è ½ÃÀ塤ºÎ¹®º° ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2020-2030³â
    • ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, Áö¿ªº°, 2020-2030³â
    • ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, ÇÁ·Î¼¼½ºº°, 2020-2030³â
    • ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, ÀÚµ¿È­ À¯Çüº°, 2020-2030³â
    • ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2020-2030³â
  • ÁÖ¿ä µ¿Çâ
  • ÃßÁ¤ Á¶»ç ¹æ¹ý
  • Á¶»ç °¡Á¤

Á¦2Àå ¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • ¿¬±¸ ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • ¾÷°è ÁøÈ­
    • Á¶»ç ¹üÀ§
  • ¿¬±¸ ´ë»óÀÌ µÈ ¿¬¼ö
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå ¿ªÇÐ

  • ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå¿¡ ´ëÇÑ ¿µÇ⠺м®(2020-2030)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
      • ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
      • Á¦¾à ºÐ¾ßÀÇ ¿¬±¸°³¹ß °¡¼Ó Çʿ伺
      • ÀÎÀû ½Ç¼ö ¹èÁ¦ÀÇ Çʿ伺
    • ½ÃÀå °úÁ¦
      • Áß¼Ò±â¾÷ÀÇ ³·Àº µµÀÔ·ü
      • ½ÇÇè½Ç ÀÚµ¿È­ ±â¼úÀÇ ³ôÀº ºñ¿ë
    • ½ÃÀå ±âȸ
      • ½ÇÇè½Ç ÀÚµ¿È­¸¦ À§ÇÑ ¾ÖÇø®ÄÉÀÌ¼Ç ¼ö°¡ Áõ°¡
      • ¼ÒÇüÈ­ Ãß¼¼ °­È­

Á¦4Àå ½ÇÇè½Ç ÀÚµ¿È­ ¼¼°è ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's 5 Force ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸ
    • ±â¼úÀû
    • ȯ°æ
    • ¹ýÀû
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19 °¨¿°ÁõÀÇ ¿µÇ⠺м®
  • ÆÄ±«ÀûÀÎ µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °üÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ Ãßõ»çÇ×°ú °á·Ð

Á¦5Àå ¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : ÇÁ·Î¼¼½ºº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : ÇÁ·Î¼¼½ºº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : ÇÁ·Î¼¼½ºº°, ÃßÁ¤°ú ¿¹Ãø, 2020-2030³â
  • ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ¿¬¼Ó Ç÷οì
    • µð½ºÅ©¸®Æ® ó¸®

Á¦6Àå ¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, ÀÚµ¿È­ À¯Çüº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : ÀÚµ¿È­ À¯Çüº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : ÀÚµ¿È­ À¯Çüº°, ÃßÁ¤°ú ¿¹Ãø, 2020-2030³â
  • ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ÅäÅ» ÀÚµ¿È­ ½Ã½ºÅÛ
    • ¸ðµâ·¯ ÀÚµ¿È­ ½Ã½ºÅÛ

Á¦7Àå ¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤°ú ¿¹Ãø, 2020-2030³â
  • ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ÀÓ»óÈ­ÇÐ ºÐ¼®
    • Ãø±¤°ú Çü±¤ ÃøÁ¤
    • ¸é¿ªÃøÁ¤ ºÐ¼®
    • ÀüÇØÁú ºÐ¼®
    • ±âŸ ÃÖÁ¾ ¿ëµµ

Á¦8Àå ¼¼°èÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, Áö¿ªº° ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå, Áö¿ª ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • ÇÁ·Î¼¼½º ³»¿ª ÃßÁ¤°ú ¿¹Ãø, 2020-2030³â
      • ÀÚµ¿È­ À¯Çü ³»¿ª ÃßÁ¤°ú ¿¹Ãø, 2020-2030³â
      • ÃÖÁ¾ ¿ëµµ ³»¿ª ÃßÁ¤°ú ¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´ÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Qiagen NV
      • Áß¿äÇÑ Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ °¡¿ë¼º¿¡ µû¶ó ´Ù¸§)
      • Á¦Ç° °³¿ä
      • ÃÖ±ÙÀÇ µ¿Çâ
    • PerkinElmer Inc.
    • Thermo Fisher Scientific, Inc.
    • Siemens Healthineers
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio Tek Instruments, Inc.
    • Eppendorf Tube
    • Hudson Robotics, Inc.
    • Aurora Biomed Inc.

Á¦10Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»ç °¡Á¤
ksm 23.08.04

Global Lab Automation Market is valued at approximately USD 5.6 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.1% over the forecast period 2023-2030. The lab automation market is concerned with the application of technology and equipment to automate laboratory activities such as sample preparation, data analysis, and testing. Lab automation is becoming more common across a wide range of businesses, including pharmaceuticals, biotechnology, clinical diagnostics, and academic research. Automation can increase throughput, enhance experiment accuracy & reproducibility, remove human variability as well as error, and improve experiment correctness, all of which lead to more rapid and effective research and development. The lab automation market is likely to expand in the future, owing to rising demand for personalized medicine, the need for speedier R&D in the pharmaceutical industry, and the continued trend towards laboratory digitization and automation.

Additionally, the growing need for faster research and development and improvisation of healthcare across the emerging nations is acting as a major driver for the lab automation market. According to the Invest India, the Indian medical technology sector is projected to be worth USD 11 billion by 2030, with a CAGR of 15% over the last three years. According to International Trade Administration, in 2023, China's medical device sector is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 8.3% from 2021 to 2026, reaching $48.8 billion. Three-quarters of China's sector for medical device imports were made up of American providers, who accounted for 27.2% of China's $5.62 billion worth of medical device imports in 2021. Diagnostic imaging and consumables accounted for over 50% of the market value in the medical device subsegments. Moreover, the increasing number of lab automation applications is projected to accelerate the market growth in the near future. Among them are the generation of cell lines, synthetic biology, genomics, cellular tests, and drug discovery. Another factor anticipated to have a substantial impact on market growth in the near future is an increase in demand for miniaturization. However, the difficulty in the adoption of lab automation by small and medium sized industry turned out to be a restraint in the growth of the lab automation market.

The key regions considered for the Global Lab Automation Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the lab automation market in 2022 and is likely to hold this position throughout the forecast period. The presence of well-established healthcare infrastructure has contributed to a rise in the region's adoption of lab automation technologies. Furthermore, the local presence of significant businesses and a supportive reimbursement system in this region are driving market penetration of revolutionary solutions. Asia Pacific is expected to be the fastest growing region during the forecast period, due the factors such as increasing initiatives by regional and international players to provide accessibility to novel lab automation solutions in the market.

Major market players included in this report are:

  • Qiagen N.V.
  • PerkinElmer Inc.
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthineers
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio Tek Instruments, Inc.
  • Eppendorf Tube
  • Hudson Robotics, Inc.
  • Aurora Biomed Inc.

Recent Developments in the Market:

  • In January 2023, Agilent Technologies recently acquired Avida Biomed, a startup life science company that develops high-performance target-enrichment techniques with unique capabilities for clinical researchers employing next-generation sequencing techniques to study cancer.
  • In March 2021, Agilent Technologies and GRAIL, a healthcare startup focused on early cancer detection, announced a collaboration to create a next-generation sequencing (NGS) tool for cancer diagnosis. The cooperation is expected to increase the efficiency and accuracy of the NGS assay by leveraging Agilent's automation and sample preparation capabilities.

Global Lab Automation Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimatio: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Process, Automation Type, End Use, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Process:

  • Continuous Flow
  • Discrete Processing

By Automation Type:

  • Total Automation Systems
  • Modular Automation Systems

By End Use:

  • Clinical Chemistry Analysis,
  • Photometry & Fluorometry
  • Immunoassay Analysis
  • Electrolyte Analysis
  • Other end-uses

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Lab Automation Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Lab Automation Market, by Process, 2020-2030 (USD Billion)
    • 1.2.3. Lab Automation Market, by Automation Type, 2020-2030 (USD Billion)
    • 1.2.4. Lab Automation Market, by End Use, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Lab Automation Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Lab Automation Market Dynamics

  • 3.1. Lab Automation Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising Demand for Personalised medicine
      • 3.1.1.2. Need For Speedier R&D in the Pharmaceutical Sector
      • 3.1.1.3. Need for the Elimination Of human Error
    • 3.1.2. Market Challenges
      • 3.1.2.1. Low Uptake By small and medium sized industries
      • 3.1.2.2. High Cost of Lab Automation Techniques
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing number of Applications for Lab Automation
      • 3.1.3.2. Increasing Trend for Miniaturization

Chapter 4. Global Lab Automation Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Lab Automation Market, by Process

  • 5.1. Market Snapshot
  • 5.2. Global Lab Automation Market by Process, Performance - Potential Analysis
  • 5.3. Global Lab Automation Market Estimates & Forecasts by Process 2020-2030 (USD Billion)
  • 5.4. Lab Automation Market, Sub Segment Analysis
    • 5.4.1. Continuous Flow
    • 5.4.2. Discrete Processing

Chapter 6. Global Lab Automation Market, by automation Type

  • 6.1. Market Snapshot
  • 6.2. Global Lab Automation Market by automation Type, Performance - Potential Analysis
  • 6.3. Global Lab Automation Market Estimates & Forecasts by automation Type 2020-2030 (USD Billion)
  • 6.4. Lab Automation Market, Sub Segment Analysis
    • 6.4.1. Total Automation Systems
    • 6.4.2. Modular Automation Systems

Chapter 7. Global Lab Automation Market, by End Use

  • 7.1. Market Snapshot
  • 7.2. Global Lab Automation Market by End Use, Performance - Potential Analysis
  • 7.3. Global Lab Automation Market Estimates & Forecasts by End Use 2020-2030 (USD Billion)
  • 7.4. Lab Automation Market, Sub Segment Analysis
    • 7.4.1. Clinical Chemistry Analysis,
    • 7.4.2. Photometry & Fluorometry
    • 7.4.3. Immunoassay Analysis
    • 7.4.4. Electrolyte Analysis
    • 7.4.5. Other end-uses

Chapter 8. Global Lab Automation Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Lab Automation Market, Regional Market Snapshot
  • 8.4. North America Lab Automation Market
    • 8.4.1. U.S. Lab Automation Market
      • 8.4.1.1. Process breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. automation Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Lab Automation Market
  • 8.5. Europe Lab Automation Market Snapshot
    • 8.5.1. U.K. Lab Automation Market
    • 8.5.2. Germany Lab Automation Market
    • 8.5.3. France Lab Automation Market
    • 8.5.4. Spain Lab Automation Market
    • 8.5.5. Italy Lab Automation Market
    • 8.5.6. Rest of Europe Lab Automation Market
  • 8.6. Asia-Pacific Lab Automation Market Snapshot
    • 8.6.1. China Lab Automation Market
    • 8.6.2. India Lab Automation Market
    • 8.6.3. Japan Lab Automation Market
    • 8.6.4. Australia Lab Automation Market
    • 8.6.5. South Korea Lab Automation Market
    • 8.6.6. Rest of Asia Pacific Lab Automation Market
  • 8.7. Latin America Lab Automation Market Snapshot
    • 8.7.1. Brazil Lab Automation Market
    • 8.7.2. Mexico Lab Automation Market
  • 8.8. Middle East & Africa Lab Automation Market
    • 8.8.1. Saudi Arabia Lab Automation Market
    • 8.8.2. South Africa Lab Automation Market
    • 8.8.3. Rest of Middle East & Africa Lab Automation Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Qiagen N.V.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. PerkinElmer Inc.
    • 9.3.3. Thermo Fisher Scientific, Inc.
    • 9.3.4. Siemens Healthineers
    • 9.3.5. Danaher Corporation
    • 9.3.6. Agilent Technologies, Inc.
    • 9.3.7. Bio Tek Instruments, Inc.
    • 9.3.8. Eppendorf Tube
    • 9.3.9. Hudson Robotics, Inc.
    • 9.3.10. Aurora Biomed Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦